← Eichor
Study identifier: NCT06559371 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer

Condition: BREAST CANCER · PET/CT  ·  Sponsor: Kunwei Shen

PhaseN/A
Planned participants150
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to learn whether 68Ga-FAPI PET/CT may be used as a new effective methods for evaluating axillary lymph node efficacy after neoadjuvant treatment for breast cancer. The main question it aims to answer is: Could 68Ga-FAPI PET/CT effectively evaluate axillary lymph node after neoadjuvant treatment for breast cancer? Participants will have a 68Ga-FAPI PET/CT test between last neoadjuvant therapy and surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Xiaosong Chen  ·  86-21-64370045  ·  zsj_mu@yeah.net

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Jiao Tong University School of Medicine, Ruijin HospitalShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06559371